Comment on “Targeting AMPK, mTOR and β-Catenin by Combined Metformin and Aspirin Therapy in HCC: An Appraisal in Egyptian HCC Patients”
Letter to the Editor
- 28 Downloads
Compliance with Ethical Standards
This letter did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Conflict of interest
GY has no potential conflict of interest relevant to this letter to report.
© Springer International Publishing AG, part of Springer Nature 2018